Abstract:Trauma is the leading cause of death for adults under the age of 44. Internal bleeding remains a significant challenge in medical emergencies, necessitating the development of effective hemostatic materials that could be administered by paramedics before a patient is in the hospital and treated by surgeons. In this study, we introduce a graphene oxide (GO)-based PEGylated synthetic hemostatic nanomaterial with an average size of 211 ± 83 nm designed to target internal bleeding by mimicking the role of fibrinogen. Functionalization of GO-g-PEG with peptides derived from the α-chain of fibrinogen, such as GRGDS, or the γ-chain of fibrinogen, such as HHLGGAKQAGDV:H12, was achieved with peptide loadings of 72 ± 6 and 68 ± 15 μM, respectively. In vitro studies with platelet-rich plasma (PRP) under confinement demonstrated aggregation enhancement of 39 and 24% for GO-g-PEG-GRGDS and GO-g-PEG-H12, respectively, compared to buffer, while adenosine diphosphate (ADP) alone induced a 5% aggregation. Compared to the same materials in the absence of ADP, GO-g-PEG-GRGDS achieved a 47% aggregation enhancement, while GO-g-PEG-H12 a 25% enhancement. This is particularly important for injectable hemostats and highlights the fact that our nanographene-based materials can only act as hemostats in the presence of agonists, reducing the possibility of unwanted clotting during circulation. Further studies on collagen-coated wells under dynamic flow revealed statistically significant augmentation of PRP fluorescence signal using GRGDS- or H12-coated GO-g-PEG compared to controls. Hemolysis studies showed <1% lysis of red blood cells (RBCs) at the highest PEGylated nanographene concentration. Finally, whole human blood coagulation studies reveal faster and more pronounced clotting using our nanohemostats vs PBS control from 3 min and below (blood is clotted with 10% CaCl2 within 4-5 min), with the biggest differences to be shown at 2 and 1 min. At 1 min, the clot weight was found to be ∼45% of that between 4 and 5 min, while no clot was formed in PBS-treated blood. Reduction of CaCl2 to 5 and 3%, or utilization of prostaglandin E1, an anticoagulant, still leads to clots but of smaller weight. The findings highlight the potential of our fibrinogen-mimic PEGylated nanographene as a promising non-hemolytic injectable scaffold for targeting internal bleeding, offering insights into its platelet aggregation capabilities under confinement and under dynamic flow as well as its pronounced coagulation abilities.

Diaminopropionic Acid Reinforced Graphene Sponge and Its Use for Hemostasis

Polydopamine Reinforced Hemostasis of a Graphene Oxide Sponge Via Enhanced Platelet Stimulation.

Graphene-based hemostatic sponge

A Novel Chitosan-Based Sponge Coated with Self-Assembled Thrombin/tannic Acid Multilayer Films As a Hemostatic Dressing

Black hemostatic sponge based on facile prepared cross-linked graphene

Polydopamine-coated chitosan/calcium pyrophosphate hybrid microflowers as an effective hemostatic agent.

Dialdehyde starch cross-linked aminated gelatin sponges with excellent hemostatic performance and biocompatibility

Bio-inspired, Bio-Degradable Adenosine 5′-Diphosphate-modified Hyaluronic Acid Coordinated Hydrophobic Undecanal-Modified Chitosan for Hemostasis and Wound Healing

Facile fabrication of diatomite‐based sponge with high biocompatibility and rapid hemostasis

Hydrophilic chitosan/graphene oxide composite sponge for rapid hemostasis and non-rebleeding removal

Fabrication and hemostasis evaluation of a carboxymethyl chitosan/sodium alginate/Resina Draconis composite sponge

NanoGraphene Clot: A New Fibrinogen-Mimic Hemostatic Material

Graphene-ophicalcite heterogeneous composite sponge for rapid hemostasis

Polydopamine-Coated Polycaprolactone Electrospun Nanofiber Membrane Loaded with Thrombin for Wound Hemostasis

Effects of degree of deacetylation on hemostatic performance of partially deacetylated chitin sponges

Gelable and Adhesive Powder for Lethal Non‐Compressible Hemorrhage Control

Biodegradable Alginate-Based Sponge with Antibacterial and Shape Memory Properties for Penetrating Wound Hemostasis

Agarose Cryogels Loaded with Polydopamine Microspheres for Sustainable Wound Care with Enhanced Hemostatic and Antioxidant Properties

Polydopamine-Coated Silk Fiber with Controllable Length for Enhanced Hemostatic Application

Self-expanding cellulose sponge with enhanced hemostatic ability by tannic acid/metal ion composite coating for highly effective hemostasis of difficult-to-control bleeding wounds

Synergistic effect of protein foams and polysaccharide on the invisible hemostasis of acellular dermal matrix sponges